Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot randomized controlled trial of sitagliptin for depressive symptoms in type 2 diabetes
2015-004527-32Phase 2Completed
- Sponsor
- King's College London
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of sitagliptin in major depressive disorder (MDD) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by King's College London. Primary endpoint: Change in depressive symptoms at 12 weeks. Started Sep 2016; status: completed.
02
Drugs
sitagliptin
03
Conditions
major depressive disorder (MDD)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-004527-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004527-32.